People’s Vaccine: Calls Grow for Equal Access to Coronavirus Vaccine as Rich Countries Hoard Supply
While the United States, Britain and other wealthy countries race to vaccinate their populations against the coronavirus, a new report finds that as much as 90 percent of the population in dozens of poorer countries could be forced to wait until at least 2022 because wealthy countries are hoarding so much of the vaccine supply. A growing movement is calling for the development of a people’s vaccine and the suspension of intellectual property rights to expand access. "Democracy Now!" speaks with Dr. Mohga Kamal-Yanni, a policy adviser to the People’s Vaccine Alliance, and Achal Prabhala, a public health advocate and coordinator of the AccessIBSA project, which campaigns for access to medicines in India, Brazil and South Africa.